In her testimony, Cheung detailed her growing concerns about the company's devices failing quality control tests in the research lab as well as what she said was a manipulation of data to pass quality control. This made her question the capabilities of the startup's proprietary testing machine, which she said was only being used on a small number of tests at the time it was hailed as the company's revolutionary innovation.
She testified she had"amassed a lot of evidence" suggesting that the company's technology wasn't adequate and she didn't feel comfortable running patient tests.
Build back better is nothing to know how I build myself by drinking to know how I cared my Father. In front of me when many nation fails it's my success. Be a man.
Maybe they just didn't calculate the proportionate control range of values correctly given the sample size. It's not like it was a Ricoh Analyzer or a Kodak
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Fonte: CNBC - 🏆 12. / 72 Consulte Mais informação »